[
    [
        {
            "time": "",
            "original_text": "“药明系”康泰生物被卷入疫苗舆论漩涡 投资人通和毓承浮出水面",
            "features": {
                "keywords": [
                    "康泰生物",
                    "疫苗",
                    "舆论漩涡",
                    "投资人",
                    "通和毓承"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "“药明系”康泰生物被卷入疫苗舆论漩涡 投资人通和毓承浮出水面",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]